BC
GILD icon

Barrett & Company’s Gilead Sciences GILD Stock Holding History

Barrett & Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16
Closed -$1.1K – 588
2024
Q2 		$1.1K Hold
16
– – ﹤0.01% 563
2024
Q1 		$1.17K Hold
16
– – ﹤0.01% 571
2023
Q4 		$1.3K Hold
16
– – ﹤0.01% 558
2023
Q3 		$1.2K Buy
+16
New +$1.23K ﹤0.01% 574

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Barrett & Company's GILD Position: Q3 2024 in Review

Barrett & Company sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 16 shares — an estimated $1.1K sold.

Barrett & Company first reported a position in GILD in Q3 2023 and held it in 4 quarters. The position peaked at $1.3K in Q4 2023. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Barrett & Company reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Barrett & Company sold 16 Gilead Sciences shares in Q3 2024, an estimated $1.1K.
  • Barrett & Company first reported a position in Gilead Sciences in Q3 2023 and held it in 4 quarters.
  • Barrett & Company's Gilead Sciences position peaked at $1.3K in Q4 2023.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Barrett & Company's 13F filing for Q3 2024, filed 24 Oct 2024.